Your browser doesn't support javascript.
loading
Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathway.
Li, Jiangjin; Xiang, Xiaoli; Gong, Xiaoxuan; Shi, Yafei; Yang, Jing; Xu, Zuo.
Affiliation
  • Li J; Department of Cardiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China. Electronic address: jiangjin.li@outlook.com.
  • Xiang X; Department of Nephrology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China.
  • Gong X; Department of Cardiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China.
  • Shi Y; Department of Cardiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China.
  • Yang J; Department of Cardiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China.
  • Xu Z; Department of Cardiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, PR China.
Biomed Pharmacother ; 94: 995-1001, 2017 Oct.
Article in En | MEDLINE | ID: mdl-28810537

Full text: 1 Database: MEDLINE Main subject: Tetrazoles / Myocardial Reperfusion Injury / Signal Transduction / Protective Agents / PPAR gamma / STAT3 Transcription Factor / Janus Kinase 2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tetrazoles / Myocardial Reperfusion Injury / Signal Transduction / Protective Agents / PPAR gamma / STAT3 Transcription Factor / Janus Kinase 2 Type of study: Prognostic_studies Limits: Animals Language: En Journal: Biomed Pharmacother Year: 2017 Type: Article